by TractManager | Dec 21, 2022 | Emerging Technology Report
Eladocagene exuparvovec is an investigational gene replacement therapy administered by bilateral intraputaminal infusion for the treatment of aromatic L-amino acid decarboxylase deficiency.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Dec 20, 2022 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of cell suspensions prepared with the ReCell Autologous Cell Harvesting Device (Avita Medical) combined with meshed...
by TractManager | Dec 20, 2022 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of cooled radiofrequency ablation (CRFA) and pulsed radiofrequency (PRF) for the treatment of chronic low back pain (CLBP) that originates from the...
by TractManager | Dec 20, 2022 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of cryoneurolysis using the iovera° system for outpatient management of nonsurgical knee pain due to...
by TractManager | Dec 16, 2022 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the eXciteOSA device for the treatment of primary snoring and mild obstructive sleep apnea (OSA).If you have a...
Recent Comments